I'm of the understanding that it's new patients coupled with the patient who wants to take a tysabri break. You also have the copaxone patient who's sick of sticking themselves everyday.
We have to remember that they are still lacking any of their formulary documentation at this point.
Market Data 
Markets 
AI
